All Invest Securities keeps Buy on ABL Diagnostics, target price €8.7

Reuters2026/09/14 18:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

All Invest Securities reiterated a Buy rating on ABL Diagnostics in a Sept. 14, 2026 equity research report.
Target price held at EUR 8.7 per share.
Report cited strong first-half 2026 revenue growth, improved profitability, confirmed full-year guidance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260914583266) on September 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

All Invest Securities keeps Buy on ABL Diagnostics, target price €8.7

You may also like

Crypto prices